Discover effective dietary strategies and medical treatments to manage multiple sclerosis symptoms. Emphasizing balanced nutrition, reducing fats, sugar, salt, and choosing whole grains can improve health outcomes. Learn about FDA-approved medications like PONVORY™ and OCREVUS® that help control disease activity and support MS management.

Dietary Approaches for Managing Multiple Sclerosis

Multiple sclerosis (MS) is a long-lasting disease affecting the central nervous system, leading to nerve damage and disrupted communication between the brain and body. While a cure remains elusive, symptoms can be managed through lifestyle changes, medications, and proper nutrition. A balanced diet plays a crucial role in MS management, emphasizing the need to avoid foods that may worsen symptoms.

Cut Back on Saturated and Trans Fats
Consuming foods rich in saturated fats, like full-fat dairy products, fatty meats, coconut oil, and palm oil, can elevate cholesterol and increase cardiovascular risks. Trans fats, found in processed baked goods and snack foods containing hydrogenated oils, can cause blood vessel inflammation, raising stroke and heart disease risks, especially for those with MS.

Lower Sugar and Salt Levels
High sodium intake may trigger MS relapses and lead to increased blood pressure, while excess sugar can cause fatigue and weight gain—common MS symptoms. Both salt and sugar are associated with inflammation, so moderation is essential to mitigate these dietary risks.

Opt for Whole Grains Instead of Refined Carbohydrates
Refined grains like white rice, white bread, and pasta lack vital nutrients and fiber. Choosing whole grains such as brown rice, whole wheat bread, and oats enhances digestive health and can alleviate constipation, a frequent issue among MS sufferers.

Beyond diet, healthcare providers might recommend specific treatments such as:

PONVORY™ (ponesimod)
This FDA-approved oral drug is designed for relapsing MS, functioning by blocking certain immune cells from entering the brain and spinal cord to reduce disease activity. Patients can find discounts when purchasing online.

OCREVUS® (ocrelizumab)
This infusion therapy targets immune B cells involved in MS. Administered every six months during clinical visits, it helps treat relapsing and primary progressive MS. The infusion usually takes several hours, with monitoring before and after treatment.